Vanyukov Michael M, Tarter Ralph E, Conway Kevin P, Kirillova Galina P, Chandler Redonna K, Daley Dennis C
University of Pittsburgh, 3520 Forbes Ave., Suite 203, Pittsburgh, PA, 15213, USA.
National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA.
Transl Behav Med. 2016 Mar;6(1):44-54. doi: 10.1007/s13142-015-0355-7.
Risk for a disorder and the mechanisms that determine its elevation, risk factors, are the focus of medical research. Targeting risk factors should serve the goal of prevention and treatment intervention. Risk, however, is but one of the aspects of liability to a disorder, a latent trait that encompasses effects of all factors leading to or from the diagnostic threshold. The coequal but opposite aspect of liability is resistance to a disorder. The factors that increase resistance and thus enable prevention or recovery may differ from those that elevate risk. Accordingly, there are nontrivial differences between research perspectives that focus on risk and on resistance. This article shows how this distinction translates into goals and methods of research and practice, from the choice of potential mechanisms tested to the results sought in intervention. The resistance concept also differs from those of "resilience" and "protective factors," subsuming but not limited to them. The implications of the concept are discussed using substance use disorder as an example and substantiate the need for biomedical research and its translation to shift to the resistance perspective.
疾病的风险以及决定其风险升高的机制,即风险因素,是医学研究的重点。针对风险因素应服务于预防和治疗干预的目标。然而,风险只是易患某种疾病倾向的一个方面,易患倾向是一种潜在特质,涵盖了所有导致或远离诊断阈值的因素的影响。易患倾向的同等但相反的方面是对疾病的抵抗力。增加抵抗力从而实现预防或康复的因素可能与那些增加风险的因素不同。因此,关注风险和抵抗力的研究视角之间存在显著差异。本文展示了这种差异如何转化为研究和实践的目标与方法,从所测试的潜在机制的选择到干预中所寻求的结果。抵抗力的概念也不同于“复原力”和“保护因素”的概念,它包含但不限于这些概念。本文以物质使用障碍为例讨论了该概念的含义,并证实了生物医学研究及其转化需要转向抵抗力视角的必要性。